ArticleJournal of Alzheimer's disease reports2022

Reconsideration of Alzheimer's Disease Therapy from a Viewpoint of Amyloidogenic Evolvability.

Gilbert Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.